HIV drug resistance (HIVDR)
Description of HIV drug resistance patterns and its association with the risk of HIV mother to child transmission among pregnant women from southern Mozambique

- Duración
- 01/01/2023 - 31/12/2025
- Coordinador
- Raquel González
- Financiadores
- Instituto de Salud Carlos III
HIV drug resistance (HIVDR) can compromise the effectiveness of antiretroviral therapy (ART), which is particularly important among pregnant women from sub-Saharan Africa due to the high burden of infection in the region and the risk of HIV mother to child transmission (MTCT).
Objective
To describe the prevalence and characteristics of HIVDR mutations among Mozambican pregnant women before and after dolutegravir (DTG) scale up in the country, and to evaluate its association with the risk of MTCT of HIV through breastfeeding.
Methods
Plasma samples from 200 HIV-infected pregnant women with virological failure (HIV viral load> 50 c/ml) will be analyzed. HIVDR will be determined using MiSeq® in samples collected at the first antenatal care visit and at delivery. In a sub-sample of participants, the presence of HIV in breastmilk will also be analyzed.
Total Funding
123,000 EUR
Nuestro equipo
Coordinator
-
Raquel González Assistant Research Professor
ISGlobal Team
-
Aina Casellas Torrentó
-
Antía Figueroa Técnica de investigación
Otros proyectos
Ver proyectos pasadosCaDMIA-plus
Validación continuada de la autopsia mínimamente invasiva (MIA) para la investigación de la causa de muerte en niños pequeños, y desarrollo de un centro de investigación y formación sobre el estudio de la causa de muerte
TIPTOP
Transforming IPT for optimal pregnancy
METRO
Measuring community prevalence among HIV exposed children in rural Southern Mozambique
MAMAH
Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women
Infección por virus Zika en mujeres embarazadas que han viajado a zonas afectadas y evaluación de impacto en salud infantil
ICARIA
Improving Care through Azithromycin Research for Infants in Africa
MIBio
Identification of Prematurity and Pre-Eclampsia as Causes of Mortality
STREESCO
Strengthening Epidemiological Surveillance in Benin and Burkina Faso for an Effective Response to COVID-19
MULTIPLY
MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention
MA-CoV
Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations
IPERVAC-SL
Impact of perceptions of COVID-19 vaccines on health-seeking behaviours in Sierra Leone
RESPIRE
Respiratory syncytial virus (RSV) in African pregnant women and children
VITAL
Towards preparedness for new maternal vaccinations: Understanding barriers and facilitators to maternal vaccine acceptance
SARA (SARS-CoV-2 and Acetylsalicylic acid)
Efficacy of low dose acetylsalicylic acid in preventing adverse maternal and perinatal outcomes in SARS-CoV-2 infected pregnant women